ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Sun Pharma, Dr Reddy's pull drugs in US over manufacturing issues: USFDA
Sun Pharma and Dr Reddy's Laboratories are recalling products in the American market due to manufacturing issues, the US Food and Drug Administration (USFDA) has said. In its latest Enforcement Report, the US health regulator stated that a US-based unit of
Announcement as on 30 May 2024

Dr Reddy's, Cipla, Sun Pharma & others to see FY25 revenue boost in key US market, says India Ratings and Research
Indian drugmakers, such as Dr Reddy's, Cipla, and Sun Pharma, are projected to maintain revenue growth in fiscal 2025, driven by drug shortages in the U.S. market. With 233 drugs in short supply, Indian companies are poised to benefit from the challenges f
Announcement as on 27 May 2024

Dr Reddy's Labs Q4 profit jumps 36% led by US growth, new products
During the quarter, the company launched 5 new products, of which 4 were launched in the US. A total of 21 products were launched during the year
Announcement as on 07 May 2024

Dr Reddy's Q4 Results: Net profit jumps 36% YoY to Rs 1307 crore
Dr Reddy's has reported a 36% year-on-year jump in quarterly net profit, helped by increase in volumes of base business, new product launches, partially offset by price erosion in certain markets.
Announcement as on 07 May 2024

Dr Reddy's Q4 PAT jumps 36% YoY to Rs 1,307 crore
The drug major's consolidated net profit increased 36.26% to Rs 1,307 crore on 12.49% rise in revenues to Rs 7,083 crore in Q4 FY24 over Q4 FY23.
Announcement as on 07 May 2024

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 14.7
  • 12Day Average: 13.88
  • 20Day Average: 13.63
  • 50Day Average: 13.51
  • 100Day Average: 13.74
  • 150Day Average: 13.75
  • 200Day Average: 13.85

RDY Indicators & signals

Indicator MACD (12,26,9)

14.16, 13.8, 0.14
Indicator MACD is in positive zone

Indicator ADX (14)

46.15, 54.29, 20
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 63
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
26 Fri Jun 2026 15.38 15.30 to 15.67 0.85% 1.48 times
25 Thu Jun 2026 15.25 14.61 to 15.27 4.02% 1.85 times
24 Wed Jun 2026 14.66 14.20 to 14.66 2.45% 1.25 times
23 Tue Jun 2026 14.31 13.80 to 14.31 2.88% 1.66 times
22 Mon Jun 2026 13.91 13.45 to 14.03 4.67% 1.29 times
18 Thu Jun 2026 13.29 13.20 to 13.36 1.06% 0.8 times
17 Wed Jun 2026 13.15 13.08 to 13.32 -1.13% 1.16 times
16 Tue Jun 2026 13.30 13.23 to 13.38 -0.23% 0.65 times
15 Mon Jun 2026 13.33 13.32 to 13.43 0.23% 0.41 times
12 Fri Jun 2026 13.30 13.30 to 13.40 -0.45% 0.47 times
11 Thu Jun 2026 13.36 13.11 to 13.40 0.45% 0.47 times
10 Wed Jun 2026 13.30 13.27 to 13.47 -0.52% 0.49 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE

 

Back to top